BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Neil Mehta, Monika Sarkar, Jennifer L. Dodge, Nicholas Fidelman, John P. Roberts, Francis Y. Yao. Intention to treat outcome of T1 hepatocellular carcinoma with the “wait and not ablate” approach until meeting T2 criteria for liver transplant listingLiver Transplantation 2016; 22(2): 178 doi: 10.1002/lt.24360
2
Wei Li, Hong Wu, Jun Han. Surgical outcomes of hepatocellular carcinoma invading hepatocaval confluenceHepatobiliary & Pancreatic Diseases International 2016; 15(6): 593 doi: 10.1016/S1499-3872(16)60152-2
3
Wai Yeow Lee, Maulana Bachtiar, Cheryl C. S. Choo, Caroline G. Lee. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analyticsBiological Reviews 2019; 94(2): 353 doi: 10.1111/brv.12457
4
Taro Takami, Takahiro Yamasaki, Issei Saeki, Toshihiko Matsumoto, Yutaka Suehiro, Isao Sakaida. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionWorld Journal of Gastroenterology 2016; 22(32): 7252-7263 doi: 10.3748/wjg.v22.i32.7252
5
Cristina Stasi, Caterina Silvestri, Fabio Voller. Hepatitis B vaccination and immunotherapies: an updateClinical and Experimental Vaccine Research 2020; 9(1): 1 doi: 10.7774/cevr.2020.9.1.1
6
Yinli Yang, Bingqing Zheng, Qiuju Han, Cai Zhang, Zhigang Tian, Jian Zhang. Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinomaCancer Biology & Therapy 2016; 17(4): 449 doi: 10.1080/15384047.2016.1156257
7
Xiao-xiao He, Liang-liang Shi, Meng-jun Qiu, Qiu-ting Li, Meng-meng Wang, Zhi-fan Xiong, Sheng-li Yang. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene familiesBiochemical and Biophysical Research Communications 2018; 504(4): 878 doi: 10.1016/j.bbrc.2018.08.203
8
Guangcong Zhang, Xiangnan Yu, Peng Liu, Xiaoxi Huang, Xuemei Jiang. Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-AnalysisDigestive Diseases and Sciences 2018; 63(12): 3207 doi: 10.1007/s10620-018-5252-8
9
Antonio Facciorusso, Valentina Del Prete, Nicola Crucinio, Nicola Muscatiello, Brian I Carr, Alfredo Di Leo, Michele Barone. Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patientsJournal of Gastroenterology and Hepatology 2015; 30(11): 1643 doi: 10.1111/jgh.12988
10
Cristina Stasi, Stefano Milani. Evolving strategies for liver fibrosis staging: Non-invasive assessmentWorld Journal of Gastroenterology 2017; 23(2): 191-196 doi: 10.3748/wjg.v23.i2.191
11
Cristina Stasi, Caterina Silvestri, Fabio Voller, Francesco Cipriani. The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccineJournal of Infection and Public Health 2016; 9(4): 389 doi: 10.1016/j.jiph.2015.05.004
12
Shuqin Zhang, Shan Gao, Man Zhao, Yunxia Liu, Yanan Bu, Qiulei Jiang, Qiang Zhao, Lihong Ye, Xiaodong Zhang. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X proteinCancer Letters 2017; 392: 94 doi: 10.1016/j.canlet.2017.02.003
13
Cristina Stasi, Elena Salomoni, Umberto Arena, Giampaolo Corti, Paolo Montalto, Filippo Bartalesi, Fabio Marra, Giacomo Laffi, Stefano Milani, Anna Linda Zignego, Massimo Pinzani. Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary studyEuropean Journal of Pharmacology 2017; 806: 105 doi: 10.1016/j.ejphar.2017.03.063
14
Naoki Yamamoto, Takahiro Yamasaki, Taro Takami, Koichi Uchida, Koichi Fujisawa, Toshihiko Matsumoto, Issei Saeki, Shuji Terai, Isao Sakaida. Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenibJournal of Clinical Biochemistry and Nutrition 2016; 58(3): 202 doi: 10.3164/jcbn.15-127
15
CHAOHUI ZUO, MAN XIA, QUNFENG WU, HAIZHEN ZHU, JINGSHI LIU, CHEN LIU. Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)Oncology Letters 2015; 9(2): 527 doi: 10.3892/ol.2014.2727
16
Chaohui Zuo, Man Xia, Jingshi Liu, Xiaoxin Qiu, Xiong Lei, Ruocai Xu, Hanchun Liu, Jianliang Li, Yongguo Li, Qinglong Li, Hua Xiao, Yuan Hong, Xiaohong Wang, Haizhen Zhu, Qunfeng Wu, Michael Burns, Chen Liu. Transcatheter Arterial Chemoembolization Combined with Interferon-α is Safe and Effective for Patients with Hepatocellular Carcinoma after Curative ResectionAsian Pacific Journal of Cancer Prevention 2015; 16(1): 245 doi: 10.7314/APJCP.2015.16.1.245
17
Xiang-Qian Gu, Wei-Ping Zheng, Da-Hong Teng, Ji-San Sun, Hong Zheng. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patientsWorld Journal of Gastroenterology 2016; 22(9): 2749-2759 doi: 10.3748/wjg.v22.i9.2749